Glendale Heights, IL — March 5, 2026 — Leads & Copy — Biologos, a manufacturer of custom sterile-filtered liquid solutions, has appointed Hetal Patel as Chief Executive Officer. The announcement coincides with the company’s 50th anniversary and follows recent investments in facilities and capabilities.
Founded in 1976, Biologos supports customers across biopharma, cell and gene therapy (CGT), tissue processing, and animal health markets.
Patel joined Biologos in 2024 as Chief Operating Officer. She has more than 25 years of experience driving commercial growth, operational excellence, and organizational transformation across regulated life sciences environments.
According to Patel, Biologos has an exceptional legacy built on integrity, agility, and customer commitment. She said that with Ampersand’s support and the investments in people, facilities, and capabilities, the company is uniquely positioned to help customers accelerate development timelines, ensure supply continuity, and scale from early research through GMP manufacturing.
Biologos operates from a 32,000-square-foot ISO 13485-certified, GMP-compliant facility in Glendale Heights, Illinois. The facility expands manufacturing capacity and was designed with built-in redundancies to ensure reliability and uninterrupted production.
An expanded footprint and centrally located fulfillment hubs enhance Biologos’ ability to support customers’ just-in-time inventory management requirements. According to the company, these investments reinforce its reputation as an agile partner capable of providing customized product solutions while maintaining adherence to rigorous quality standards.
Eric Lev, General Partner, Ampersand Capital Partners, said that Biologos has earned the trust of its customers through consistent performance and exceptional service. Lev added that with Patel’s leadership and the company’s expanded capabilities, Biologos is well positioned to deepen existing customer relationships and continue expanding into high-growth biopharma and CGT markets.
Biologos maintains a 98% customer retention rate. The company said it remains committed to delivering GMP-compliant, high-quality, cost-effective custom sterile-filtered liquid solutions that integrate seamlessly into customers’ workflows.
Biologos partners with companies in the biopharma, cell and gene therapy, tissue processing, and animal health markets to deliver custom sterile‑filtered buffers, media, reagents, and sera. The company is recognized for providing GMP‑compliant, high‑quality, and cost‑effective liquid solutions.
Source: Biologos
